NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment

CompletedNA

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo

Conditions: Neurodegenerative Diseases, Cognitive Decline, Parkinson Disease Dementia, Alzheimer Disease, Multiple Sclerosis

Interventions: Vespa software

Countries: Italy

VESPA 2.0 is based on an integrative and ecological approach used for the treatment of cognitive dysfunction in patients with MCI or other neurodegenerative disorders.

Eligibility overview

Sex: ALL

Age: 50 Years to 70 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Patients diagnosed with Alzheimer Disease, Multiple Sclerosis, Parkinson Disease
* Severity of mild to moderate cognitive impairment
* Sign informed consent

Exclusion Criteria:

* Important comorbidities with psychiatric syndromes
* Failure to sign the informed consent
* Atypical parkinsonisms
* Clinical conditions that involve vision-related problems.

Locations (1)

Messina, Sicily, Italy